Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_assertion type Assertion NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_head.
- NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_assertion description "[The FCGR2A 131RR and FCGR3A 158VV genotypes were over-represented [OR: 1.67 (1.05-2.63) and 2.04 (1.06-4.00), respectively] whereas the FCGR3B NA2NA2 was under-represented in patients with cryptococcosis (28% vs. 40% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_provenance.
- NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_assertion evidence source_evidence_literature NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_provenance.
- NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_assertion SIO_000772 17710620 NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_provenance.
- NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_assertion wasDerivedFrom befree-2016 NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_provenance.
- NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_assertion wasGeneratedBy ECO_0000203 NP626094.RAa_QNvVBnWPR4jZ5Fuz1eCgfUOWFekYHkGI3wnqYDsoY130_provenance.